Richard Cheng

Richard Cheng, MD, MSc is a HF cardiologist and cardio-oncologist with a focus on education, risk stratification, imaging, and treatment strategies for HF, cardiomyopathies, cardiac amyloidosis and cancer therapy-associated cardiac dysfunction. His recent research interests include the prevention of cardiovascular disease, epidemiology, and long-term cardiovascular complications of cancer treatment in breast cancer survivors and stem cell transplant recipients. He also has ongoing studies focused on risk stratification, multimodality imaging and outcomes in cardiac amyloidosis, cardiomyopathies, heart transplantation and LVAD recipients. He serves on the editorial boards of JACC, JACC: Cardio-Oncology, ACC.org, Heart, and the Journal of Heart and Lung Transplantation.